These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19571794)

  • 41. Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.
    McFadden LM; Hoonakker AJ; Vieira-Brock PL; Stout KA; Sawada NM; Ellis JD; Allen SC; Walters ET; Nielsen SM; Gibb JW; Alburges ME; Wilkins DG; Hanson GR; Fleckenstein AE
    Synapse; 2011 Aug; 65(8):771-7. PubMed ID: 21190217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.
    Bhimani RV; Vik M; Wakabayashi KT; Szalkowski C; Bass CE; Park J
    J Neurochem; 2021 Aug; 158(4):865-879. PubMed ID: 34265079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity.
    Volz TJ; Farnsworth SJ; Rowley SD; Hanson GR; Fleckenstein AE
    Synapse; 2009 Feb; 63(2):147-51. PubMed ID: 19021208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of dopamine D3 receptor and dopamine transporter in methamphetamine-induced behavioral sensitization in tree shrews.
    Huang J; Yang G; Li Z; Leung CK; Wang W; Li Y; Liu L; Shen B; He C; He Y; Zeng X; Li J
    Brain Behav; 2020 Feb; 10(2):e01533. PubMed ID: 31943832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compulsive methamphetamine taking under punishment is associated with greater cue-induced drug seeking in rats.
    Torres OV; Jayanthi S; Ladenheim B; McCoy MT; Krasnova IN; Cadet JL
    Behav Brain Res; 2017 May; 326():265-271. PubMed ID: 28284948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methamphetamine-, d-Amphetamine-, and p-Chloroamphetamine-Induced Neurotoxicity Differentially Effect Impulsive Responding on the Stop-Signal Task in Rats.
    Furlong TM; Leavitt LS; Keefe KA; Son JH
    Neurotox Res; 2016 May; 29(4):569-82. PubMed ID: 26846719
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ; Yamamoto BK
    J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences.
    Davidson C; Lee TH; Ellinwood EH
    Neurochem Int; 2005 Feb; 46(3):189-203. PubMed ID: 15670635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neonatal brain inflammation enhances methamphetamine-induced reinstated behavioral sensitization in adult rats analyzed with explainable machine learning.
    Wang KC; Ojeda NB; Wang H; Chiang HS; Tucci MA; Lee JW; Wei HC; Kaizaki-Mitsumoto A; Tanaka S; Dankhara N; Tien LT; Fan LW
    Neurochem Int; 2024 Jun; 176():105743. PubMed ID: 38641026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
    Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.
    Krasnova IN; Justinova Z; Ladenheim B; Jayanthi S; McCoy MT; Barnes C; Warner JE; Goldberg SR; Cadet JL
    PLoS One; 2010 Jan; 5(1):e8790. PubMed ID: 20098750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurotoxicity to dopamine neurons after the serial exposure to alcohol and methamphetamine: Protection by COX-2 antagonism.
    Blaker AL; Rodriguez EA; Yamamoto BK
    Brain Behav Immun; 2019 Oct; 81():317-328. PubMed ID: 31228610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.
    Pittenger ST; Barrett ST; Chou S; Bevins RA
    Behav Brain Res; 2016 Mar; 300():150-9. PubMed ID: 26638833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.
    McFadden LM; Hunt MM; Vieira-Brock PL; Muehle J; Nielsen SM; Allen SC; Hanson GR; Fleckenstein AE
    Drug Alcohol Depend; 2012 Nov; 126(1-2):87-94. PubMed ID: 22647900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
    Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake.
    Rau KS; Birdsall E; Volz TJ; Riordan JA; Baucum AJ; Adair BP; Bitter R; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):676-82. PubMed ID: 16687477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
    Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.
    Segal DS; Kuczenski R
    J Neurosci; 1997 Apr; 17(7):2551-66. PubMed ID: 9065515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine.
    Lee NR; Zheng G; Leggas M; Janganati V; Nickell JR; Crooks PA; Bardo MT; Dwoskin LP
    J Pharmacol Exp Ther; 2019 Nov; 371(2):526-543. PubMed ID: 31413138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Region-specific changes in markers of neuroplasticity revealed in HIV-1 transgenic rats by low-dose methamphetamine.
    Ohene-Nyako M; Persons AL; Napier TC
    Brain Struct Funct; 2018 Sep; 223(7):3503-3513. PubMed ID: 29931627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.